This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013:2013:420928.
doi: 10.1155/2013/420928. Epub 2013 Apr 17.

Fifteen years of annual mass treatment of onchocerciasis with ivermectin have not interrupted transmission in the west region of cameroon

Affiliations

Fifteen years of annual mass treatment of onchocerciasis with ivermectin have not interrupted transmission in the west region of cameroon

Moses N Katabarwa et al. J Parasitol Res. 2013.

Abstract

We followed up the 1996 baseline parasitological and entomological studies on onchocerciasis transmission in eleven health districts in West Region, Cameroon. Annual mass ivermectin treatment had been provided for 15 years. Follow-up assessments which took place in 2005, 2006, and 2011 consisted of skin snips for microfilariae (mf) and palpation examinations for nodules. Follow-up Simulium vector dissections for larval infection rates were done from 2011 to 2012. mf prevalence in adults dropped from 68.7% to 11.4%, and nodule prevalence dropped from 65.9% to 12.1%. The decrease of mf prevalence in children from 29.2% to 8.9% was evidence that transmission was still continuing. mf rates in the follow-up assessments among adults and in children levelled out after a sharp reduction from baseline levels. Only three health districts out of 11 were close to interruption of transmission. Evidence of continuing transmission was also observed in two out of three fly collection sites that had infective rates of 0.19% and 0.18% and ATP of 70 (Foumbot) and 300 (Massangam), respectively. Therefore, halting of annual mass treatment with ivermectin cannot be done after 15 years as it might escalate the risk of transmission recrudescence.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Map of West Region of Cameroon showing the study areas.
Figure 2
Figure 2
Comparison of mf rates among adults and children at baseline, 1996, with followup surveys in 2005, 2006, and 2011 in West Region of Cameroon.
Figure 3
Figure 3
Monthly seasonal biting of Simulium flies at 3 fly catching sites in West Region.

References

    1. Cupp EW, Cupp MS. Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year. The American Journal of Tropical Medicine and Hygiene. 2005;73(6):1159–1161. - PubMed
    1. Taylor HR, Pacque M, Munoz B, Greene BM. Impact of mass treatment of onchocerciasis with ivermectin on the transmission of infection. Science. 1990;250(4977):116–118. - PubMed
    1. Borsboom GJJM, Boatin BA, Nagelkerke NJD, et al. Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa. Filaria Journal. 2003;2, article 8 - PMC - PubMed
    1. Hopkins AD. Ivermectin and onchocerciasis: is it all solved? Eye. 2005;19(10):1057–1066. - PubMed
    1. Yaméogo L. Special intervention zones. Annals of Tropical Medicine and Parasitology. 2008;102(supplement 1):23–24. - PubMed

LinkOut - more resources

Cite

AltStyle によって変換されたページ (->オリジナル) /